XML 19 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2019   61,635,477      
Beginning balance at Dec. 31, 2019 $ 352,485 $ 7 $ 686,390 $ (334,170) $ 258
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock (in shares)   404,637      
Exercise of stock option (in shares)   4,309      
Exercise of stock options 15   15    
Stock-based compensation 8,244   8,244    
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)   49,889      
Issuance of common stock pursuant to Employee Stock Purchase Plan 556   556    
Net loss (54,074)     (54,074)  
Other comprehensive income (loss) (763)       (763)
Ending balance (in shares) at Mar. 31, 2020   62,094,312      
Ending balance at Mar. 31, 2020 306,463 $ 7 695,205 (388,244) (505)
Beginning balance (in shares) at Dec. 31, 2019   61,635,477      
Beginning balance at Dec. 31, 2019 352,485 $ 7 686,390 (334,170) 258
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (120,944)        
Other comprehensive income (loss) 309        
Ending balance (in shares) at Jun. 30, 2020   71,972,610      
Ending balance at Jun. 30, 2020 420,324 $ 8 874,863 (455,114) 567
Beginning balance (in shares) at Mar. 31, 2020   62,094,312      
Beginning balance at Mar. 31, 2020 306,463 $ 7 695,205 (388,244) (505)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock (in shares)   404,637      
Issuance of common stock in connection with public offering, net of underwriting discounts, commissions, and offering costs (in shares)   9,433,963      
Issuance of common stock in connection with public offering, net of underwriting discounts, commissions, and offering costs 117,094 $ 1 117,093    
Equity component of convertible note issuance 53,635   53,635    
Debt issuance costs attributable to convertible feature (109)   (109)    
Exercise of stock option (in shares)   39,698      
Exercise of stock options 139   139    
Stock-based compensation 8,900   8,900    
Net loss (66,870)     (66,870)  
Other comprehensive income (loss) 1,072       1,072
Ending balance (in shares) at Jun. 30, 2020   71,972,610      
Ending balance at Jun. 30, 2020 420,324 $ 8 874,863 (455,114) 567
Beginning balance (in shares) at Dec. 31, 2020   73,874,904      
Beginning balance at Dec. 31, 2020 320,684 $ 8 897,607 (577,530) 599
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock (in shares)   238,962      
Exercise of stock option (in shares)   5,721      
Exercise of stock options 15   15    
Stock-based compensation 8,708   8,708    
Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)   95,004      
Issuance of common stock pursuant to Employee Stock Purchase Plan 759   759    
Issuance of common stock for restricted stock units vested (in shares)   278,559      
Net loss (57,641)     (57,641)  
Other comprehensive income (loss) (441)       (441)
Ending balance (in shares) at Mar. 31, 2021   74,493,150      
Ending balance at Mar. 31, 2021 272,084 $ 8 907,089 (635,171) 158
Beginning balance (in shares) at Dec. 31, 2020   73,874,904      
Beginning balance at Dec. 31, 2020 $ 320,684 $ 8 897,607 (577,530) 599
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock option (in shares) 109,643        
Net loss $ (117,473)        
Other comprehensive income (loss) (325)        
Ending balance (in shares) at Jun. 30, 2021   74,834,952      
Ending balance at Jun. 30, 2021 220,693 $ 8 915,414 (695,003) 274
Beginning balance (in shares) at Mar. 31, 2021   74,493,150      
Beginning balance at Mar. 31, 2021 272,084 $ 8 907,089 (635,171) 158
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock (in shares)   231,710      
Vesting of restricted stock 0        
Exercise of stock option (in shares)   103,922      
Exercise of stock options 271   271    
Stock-based compensation 8,054   8,054    
Issuance of common stock for restricted stock units vested (in shares)   6,170      
Net loss (59,832)     (59,832)  
Other comprehensive income (loss) 116       116
Ending balance (in shares) at Jun. 30, 2021   74,834,952      
Ending balance at Jun. 30, 2021 $ 220,693 $ 8 $ 915,414 $ (695,003) $ 274